High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid

Aberrant activation of lymphoid enhancer-binding factor-1 (LEF1) has been identified in several cancers, including chronic lymphocytic leukemia (CLL). As a key transcription factor of the Wnt/β-catenin pathway, LEF1 helps to regulate important genes involved in tumor cell death mechanisms. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wei, Zhu, Huayuan, Fu, Yuan, Shen, Wenyi, Miao, Kourong, Hong, Min, Xu, Wei, Fan, Lei, Young, Ken H., Liu, Peng, Li, Jianyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008311/
https://www.ncbi.nlm.nih.gov/pubmed/26950276
http://dx.doi.org/10.18632/oncotarget.7795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008311/
https://www.ncbi.nlm.nih.gov/pubmed/26950276
http://dx.doi.org/10.18632/oncotarget.7795

Ejemplares similares